Investigation of Lipoxin A4, Annexin A1 and Interleukin-1 Beta Levels in Individuals With Periodontitis.
Lipoxin A4
2 other identifiers
observational
60
1 country
1
Brief Summary
Since the researchers thought that Annexin A1, Lipoxin A4 and IL-1 Beta parameters, which have been found to be related to inflammatory conditions, may increase in periodontitis, a common inflammatory gum disease, we wanted to evaluate the changes in Annexin A1, Lipoxin A4 and IL-1 Beta levels in the Gingival Crevicular Fluid of participants with periodontitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 15, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedNovember 21, 2024
November 1, 2024
8 months
November 15, 2024
November 19, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in Annexin and Lipoxin parameters in CGF in periodontal disease
We expect Annexin and Lipoxin parameters to decrease and IL-1b levels to increase in periodontal disease.
6 mounth
Study Arms (2)
Control group
Healthy group
Test group
Stage III Grade C Periodontitis
Interventions
Periodontal clinical parameters and Annexin and Lipoxin parameters in CGF will be compared between the test and control groups
Eligibility Criteria
Patients applying to Kahramanmaraş Sütçü İmam University, Faculty of Dentistry, Department of Periodontics
You may qualify if:
- The patient must be a volunteer
- He/she must be over 18 years old
- He/she must not have any systemic disease
You may not qualify if:
- Smoking, drinking alcohol
- Being pregnant or breastfeeding
- Not volunteering
- Having had periodontal treatment in the last 6 months
- Having used antibiotics or anti-inflammatory drugs in the last 6 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaraş Sütçü İmam University, Faculty of Dentistry, Department of Periodontics
Kahramanmaraş, Onikişubat, 46000, Turkey (Türkiye)
Related Publications (4)
Tobon-Arroyave SI, Isaza-Guzman DM, Gomez-Ortega J, Florez-Alzate AA. Salivary levels of specialized pro-resolving lipid mediators as indicators of periodontal health/disease status. J Clin Periodontol. 2019 Oct;46(10):978-990. doi: 10.1111/jcpe.13173. Epub 2019 Aug 20.
PMID: 31339183BACKGROUNDCasarin RCV, Salmon CR, Stolf CS, Paz HES, Rangel TP, Domingues RR, Pauletti BA, Paes-Leme AF, Araujo C, Santamaria MP, Ruiz KS, Monteiro MF. Salivary annexin A1: A candidate biomarker for periodontitis. J Clin Periodontol. 2023 Jul;50(7):942-951. doi: 10.1111/jcpe.13803. Epub 2023 Mar 19.
PMID: 36935103BACKGROUNDMa R, Liu Y, Xu Y, Duan D. Lipoxin A4 levels predict site-specific clinical improvements post scaling and root planing and correlate negatively with periodontal pathogens in severe periodontitis. BMC Oral Health. 2024 Feb 8;24(1):204. doi: 10.1186/s12903-024-03948-w.
PMID: 38331747BACKGROUNDSchenkein HA, Papapanou PN, Genco R, Sanz M. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000. 2020 Jun;83(1):90-106. doi: 10.1111/prd.12304.
PMID: 32385879BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 60 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 15, 2024
First Posted
November 21, 2024
Study Start
March 16, 2024
Primary Completion
October 31, 2024
Study Completion
November 1, 2024
Last Updated
November 21, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
ı don't want to share